GPT and Hepatic steatosis: Besides, the administration of n-3 PUFAs by parenteral nutrition of C57BL6 mice protected the liver against hepatic steatosis with improvement in liver architecture, decreased aspartate aminotransferase (AST) and ALT serum levels, an amelioration of liver fat content and a reversion of the essential fatty acid’s deficiency [105].